NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating potential securities claims on behalf of purchasers of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) (“Evolv” or the “Company”). Evolv Technologies Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, develops AI-based touch-less screening technologies for weapons detection, ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. (NASDAQ: EVLV, NHIC) resulting from allegations that Evolv may have issued materially misleading business information to the investing public.So What: If you purchased Evolv and/or NewHold Investment Corp. securities you may be entitled to compensation without pay ...

Core Viewpoint - Evolv Technologies Holdings, Inc. is under investigation for potential violations of federal securities laws following a significant drop in its stock price due to an internal investigation revealing material misstatements in revenue recognition dating back to 2022 [1][2]. Group 1: Company Financials - On October 25, 2024, Evolv Technologies announced a delay in filing its quarterly financial report due to the internal investigation [1]. - The investigation revealed that certain financial statements from 2022 to mid-2024 should not be relied upon, as undisclosed terms in sales to channel partners affected reported revenue [1]. Group 2: Stock Performance - The announcement led to a drastic decline in Evolv's stock price, which fell by more than 40% during trading on October 25, 2024 [2]. Group 3: Legal Implications - Bleichmar Fonti & Auld LLP is encouraging investors in Evolv Technologies to seek additional information regarding potential legal options [2].

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Evolv Technologies Holdings, Inc. ("Evolv" or the "Company") (NASDAQ: EVLV) on behalf of Evolv stockholders. Our investigation concerns whether Evolv has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On October 25, 2024, before market hours, Evolv filed a Cur ...

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolv Technologies Holdings, Inc. ("Evolv" or "the Company") (NASDAQ: EVLV). Investors who purchased Evolv securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/EVLV. Investigation Details On October 25, 2024, Evolv filed a Current Report on Form 8-K with the SEC, announcin ...

We add real-time buy and sell signals on these, as well as other trading opportunities which we provide in our active chat community. We look at companies with a defensible competitive advantage and the opportunity and/or business models which have the potential to generate considerable operational leverage. If you are interested in similarly small, high-growth potential stocks you could join us at our marketplace service SHU Growth Portfolio , where we maintain a portfolio and a watchlist of similar stocks ...

Company Investigation - Leading securities law firm Bleichmar Fonti & Auld LLP is investigating Evolv Technologies Holdings Inc (NASDAQ: EVLV) for potential violations of federal securities laws [1] - The investigation follows Evolv's announcement of a delay in filing its quarterly financial report due to material misstatements in revenue recognition dating back to 2022 [1] - Evolv disclosed that certain financial statements from 2022 to mid-2024 should not be relied upon due to undisclosed terms in sales to channel partners, including one of its largest partners [1] Stock Performance - Evolv's stock price declined more than 40% during trading on October 25, 2024, following the announcement of the financial reporting issues [2] Legal Representation - Bleichmar Fonti & Auld LLP is a leading international law firm specializing in securities class actions and shareholder litigation [3] - The firm has achieved notable successes, including recovering over $900 million from Tesla Inc's Board of Directors and $420 million from Teva Pharmaceutical Ind Ltd [3] - BFA was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been recognized by Law360 and Thompson Reuters [3]

Core Viewpoint - Berman Tabacco is investigating potential securities law violations by Evolv Technologies Holdings, Inc. following the company's disclosure of an internal investigation into its sales practices [1][2]. Investigation Details - On October 25, 2024, Evolv filed a Form 8-K with the U.S. Securities and Exchange Commission, revealing that an independent committee has started investigating the company's sales practices [2]. - The committee found that certain sales, particularly to a major channel partner, involved extra-contractual terms not disclosed to the accounting team, indicating potential misconduct by company personnel [2]. - Preliminary findings suggest that the accounting for specific sales transactions was inaccurate, with revenue being prematurely or incorrectly recognized in financial statements from Q2 2022 to Q2 2024 [2].

NEW YORK, Oct. 27, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) resulting from allegations that Evolv may have issued materially misleading business information to the investing public. So What: If you purchased Evolv securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...

Core Viewpoint - Evolv Technologies Holdings, Inc. is under investigation for potential violations of federal securities laws following a significant drop in its stock price due to an internal investigation revealing material misstatements in revenue recognition dating back to 2022 [1][2]. Group 1: Company Financial Issues - On October 25, 2024, Evolv Technologies announced a delay in filing its quarterly financial report due to an internal investigation [1]. - The investigation uncovered material misstatements in revenue recognition, indicating that certain financial statements from 2022 to mid-2024 should not be relied upon [1]. - Sales to channel partners, including one of Evolv's largest partners, involved undisclosed terms that impacted reported revenue [1]. Group 2: Stock Market Reaction - Following the announcement, Evolv's stock price declined by more than 40% during trading on October 25, 2024 [2]. Group 3: Legal and Representation Options - Investors in Evolv Technologies are encouraged to seek legal options and submit their information to Bleichmar Fonti & Auld LLP, which operates on a contingency fee basis [2]. - Bleichmar Fonti & Auld LLP is recognized as a leading international law firm specializing in securities class actions and shareholder litigation [2].